BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) Other Operating Expenses (2020 - 2026)

Updated

BioAtla's Other Operating Expenses came in at $11,000 for Q2 2026, down 45.0% from the prior quarter.

Analysis

BioAtla (BCAB) Other Operating Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported Other Operating Expenses of $34,000, up 325.0% year-over-year.

  • The five-year range for quarterly Other Operating Expenses is $3,000 (Q3 2025) to $20,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 BioAtla 2.41 Mn -16.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Mar 31, 2026 20,000.00
Sep 30, 2025 3,000.00
Sep 30, 2024 8,000.00
Mar 31, 2020 -926,000.00
API Access

BioAtla Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCAB&period=max&api_key=YOUR_API_KEY